Source: Virtual Congress 2021 – COVID - 19 biomarkers



Rating:

Share or cite this content

Citations should be made in the following way:
F. Sanz Herrero (València, Spain), F. Puchades Gimeno (València, Spain), E. Verdejo Mengual (València, Spain), V. Abril López De Medrano (València, Spain), S. Carrascosa García (València, Spain), J. Mateo González (València, Spain), A. Lluch Bisbal (València, Spain), N. Carrión Collado (València, Spain), A. González Cruz (València, Spain), M. García Deltoro (València, Spain), E. Fernández Fabrellas (València, Spain). Pathophysiological parameters of microcirculation as determinants of mortality in SARS-CoV-2 pneumonia. 643

Member's Comments

No comment yet.

Related content which might interest you: Role of biomarkers of systemic inflammation in the prediction of mortality and/or severe complications in community adquired pneumonia Source: International Congress 2019 – Prognosis in bacterial and viral pneumonia Year: 2019 Incidence, risk factors and outcomes of nonresolving pneumonia Source: Annual Congress 2010 - The spectrum of lower respiratory tract infections: risk factors of poor outcome and diagnostic tools Year: 2010 Biomarkers and cardiovascular events in community-acquired pneumonia Source: International Congress 2016 – Community-acquired pneumonia: update on prognostic factors and therapeutic strategies Year: 2016 Potential causes of increased long-term mortality after pneumonia Source: Eur Respir J 2011; 37: 1306-1307 Year: 2011 Non-invasive mortality predictors in pediatric pulmonary hypertension Source: Annual Congress 2010 - Pulmonary circulation III Year: 2010 Predictive factors of in-hospital mortality of patients with community-acquired pneumonia Source: Eur Respir J 2006; 28: Suppl. 50, 352s Year: 2006 Survival and prognostic factors of acute exacerbations of pulmonary arterial hypertension Source: Eur Respir J 2007; 30: Suppl. 51, 342s Year: 2007 Prediction of complications development and lethal outcome in patients with community-acquired pneumonia Source: Annual Congress 2011 - The new clinical spectrum of lung diseases: from bronchi to pleura Year: 2011 Importance of cardiac biomarkers in the evaluation of acute pulmonary thromboembolism severity, mortality and complicated clinical course Source: Annual Congress 2011 - New insights in management of interstitial and vascular lung diseases Year: 2011 Biochemical predictors of mortality in pulmonary embolism Source: Annual Congress 2011 - Prediction of pulmonary thromboembolism Year: 2011 Non-invasive ventilation failure predictor factors in acute respiratory infections in children Source: Annual Congress 2012 - Application of noninvasive ventilation in non-obstructive patients Year: 2012 Treatment failure of community-acquired pneumonia: risk factors and consequences Source: Annual Congress 2012 - PG17 Clinical failure of treatment of respiratory infections Year: 2012 Pathogenic aspects of pulmonary complications in acute pancreatitis patients Source: Annual Congress 2008 - Structural remodelling in COPD Year: 2008 Pathogenic aspects of pulmonary complications in acute pancreatitis patients Source: Annual Congress 2009 - Pathological remodelling in chronic lung disease: from epithelial-mesenchymal transition to cellular activation Year: 2009 Predictive factors of mortality in patients with chronic respiratory failure Source: International Congress 2016 – Best abstracts in COPD management Year: 2016 The incidence and risk factors of ventilator associated pneumonia on the mortality in patients with traumatic brain injury Source: Annual Congress 2012 - Respiratory infections: prognosis and outcome Year: 2012 Affecting factors of mortality in severe community-acquired pneumonia Source: Eur Respir J 2005; 26: Suppl. 49, 643s Year: 2005 Role of procalcitonin in predicting severity and in-hospital mortality in patients with community-acquired pneumonia Source: International Congress 2016 – Community-acquired pneumonia: risk classes and management issues Year: 2016 Factors influencing mortality in severe community acquired pneumonia requiring mechanical ventilation Source: Eur Respir J 2006; 28: Suppl. 50, 181s Year: 2006 Biomarkers for activation of the inflammatory and immune systems in the risk of mortality in critically-ill COVID-19 patients Source: Virtual Congress 2021 – Respiratory failure in COVID19 and beyond Year: 2021